COMMUNIQUÉS West-GlobeNewswire
-
THRC’s CEO Calvin H. Knowlton, PhD Interviewed on NPR’s It’s Your Health
15/03/2018 - 13:00 -
Ovid Therapeutics Announces OV101 Granted Fast Track Designation by U.S. FDA for Treatment of Fragile X Syndrome
15/03/2018 - 13:00 -
La Jolla Pharmaceutical Company Announces Pricing of Public Offering of Common Stock
15/03/2018 - 13:00 -
HempAmericana Issues New Letter to Shareholders
15/03/2018 - 13:00 -
Checkpoint Therapeutics Announces Preclinical Data Presentation at the 2018 American Association for Cancer Research Annual Meeting
15/03/2018 - 12:30 -
Actinium Pharmaceuticals to Present at 28th Annual Oppenheimer Healthcare Conference
15/03/2018 - 12:30 -
Adaptimmune Announces Responses in Second Solid Tumor Indication with NY-ESO SPEAR T-cells
15/03/2018 - 12:30 -
TG Therapeutics, Inc. Announces Preclinical Data Presentation at the 2018 American Association for Cancer Research (AACR) Annual Meeting
15/03/2018 - 12:30 -
Adaptimmune Reports Fourth Quarter / Full Year 2017 Financial Results and Business Update
15/03/2018 - 12:30 -
Mustang Bio Announces Key Leadership Appointments
15/03/2018 - 12:30 -
FIT Biotech Oy: FIT Biotech's Review of Operations and Financial Statement 2017 published
15/03/2018 - 11:32 -
Dynavax Announces Acceptance of Two Data Abstracts for SD-101 in Combination with KEYTRUDA® for Presentation at the 2018 American Association for Cancer Research (AACR) Annual Meeting
15/03/2018 - 11:30 -
Vical Reports Fourth Quarter 2017 Financial and Operational Results
15/03/2018 - 11:30 -
BioCryst Announces Initiation of the Phase 3 APeX-2 Trial of BCX7353 in Patients with Hereditary Angioedema
15/03/2018 - 11:00 -
Histogenics Corporation Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2017
15/03/2018 - 11:00 -
Capital Senior Living Corporation to Present at the 28th Annual Oppenheimer Healthcare Conference on Tuesday, March 20, 2018
15/03/2018 - 11:00 -
BioAdaptives (OTC PINK: BDPT) Announces New Management
15/03/2018 - 11:00 -
AC Immune prepares for a first in human study of a promising positron emission tomography (PET) tracer for Parkinson's disease
15/03/2018 - 10:00 -
Affimed to Present Data on AFM24 at AACR Annual Meeting 2018
15/03/2018 - 09:01
Pages